These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37742508)

  • 1. Glycan-modified cellular nanosponges for enhanced neutralization of botulinum toxin.
    Ai X; Wang D; Noh I; Duan Y; Zhou Z; Mukundan N; Fang RH; Gao W; Zhang L
    Biomaterials; 2023 Nov; 302():122330. PubMed ID: 37742508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
    Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
    J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Loaded Cellular Nanosponges for Dual-Biomimicry Neurotoxin Countermeasure.
    Wang S; Wang D; Shen WT; Kai M; Yu Y; Peng Y; Xian N; Fang RH; Gao W; Zhang L
    Small; 2024 Apr; 20(14):e2309635. PubMed ID: 37990378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G; Lam KH; Weisemann J; Peng L; Krez N; Perry K; Shoemaker CB; Dong M; Rummel A; Jin R
    Sci Rep; 2017 Aug; 7(1):7438. PubMed ID: 28785006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Nanosponges for Biological Neutralization.
    Wang S; Wang D; Duan Y; Zhou Z; Gao W; Zhang L
    Adv Mater; 2022 Apr; 34(13):e2107719. PubMed ID: 34783078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A:
    Azzaz F; Hilaire D; Fantini J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
    Atassi MZ; Taruishi M; Naqvi M; Steward LE; Aoki KR
    Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges.
    Chen Y; Chen M; Zhang Y; Lee JH; Escajadillo T; Gong H; Fang RH; Gao W; Nizet V; Zhang L
    Adv Healthc Mater; 2018 Jul; 7(13):e1701366. PubMed ID: 29436150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L; Tepp WH; Johnson EA; Dong M
    PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design Strategies for Cellular Nanosponges as Medical Countermeasures.
    Wang S; Wang D; Kai M; Shen WT; Sun L; Gao W; Zhang L
    BME Front; 2023; 4():0018. PubMed ID: 37849681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal Cellular Nanosponges for Effective Detoxification of Neurotoxins.
    Wang D; Ai X; Duan Y; Xian N; Fang RH; Gao W; Zhang L
    ACS Nano; 2022 Nov; 16(11):19145-19154. PubMed ID: 36354967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy.
    Yin L; Masuyer G; Zhang S; Zhang J; Miyashita SI; Burgin D; Lovelock L; Coker SF; Fu TM; Stenmark P; Dong M
    PLoS Biol; 2020 Mar; 18(3):e3000618. PubMed ID: 32182233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
    Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.
    Ai X; Wang D; Honko A; Duan Y; Gavrish I; Fang RH; Griffiths A; Gao W; Zhang L
    J Am Chem Soc; 2021 Oct; 143(42):17615-17621. PubMed ID: 34647745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
    Masuyer G; Davies JR; Stenmark P
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
    Lam KH; Perry K; Shoemaker CB; Jin R
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32992561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.